ST Pharm, a pharmaceutical raw-material company which is a subsidiary of Dong-A Socio Holdings, announced that it has won the USD 7 million Export Tower at the 52nd Trade Day Commemoration Ceremony in Samsung-dong, Seoul, on Dec. 7.
The company received the export tower award thanks to its achievement of US$70 million (82.43 billion won) in exports for a year between July 2014 to June 2015. The figure surged more than 60 percent from exports during the same period last year and it accounts for nearly 75 percent of its total sales.
ST Pharm has production facilities approved by medical regulators at home and abroad, such as the U.S.’ Food and Drug Administration (FDA), Japan's Pharmaceuticals and Medical Devices Agency (PMDA) and Australia’s Therapeutic Goods Administration (TGA). Also, the company mainly produces and sells the treatments for hepatitis and tuberculosis.
An official from ST Pharm said, “With the latest export tower award, the company has laid the groundwork to become a global leader. We will not only manufacture good raw material medicines but also focus on training global talent and expanding overseas networks, so that we can win the USD 100 million Export Tower in 2016.”